Logo image of IRM

IRON MOUNTAIN INC (IRM) Stock Fundamental Analysis

NYSE:IRM - New York Stock Exchange, Inc. - US46284V1017 - REIT - Currency: USD

91.78  -1.72 (-1.84%)

After market: 91.78 0 (0%)

Fundamental Rating

2

Taking everything into account, IRM scores 2 out of 10 in our fundamental rating. IRM was compared to 29 industry peers in the Specialized REITs industry. IRM has a medium profitability rating, but doesn't score so well on its financial health evaluation. IRM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IRM was profitable.
In the past year IRM had a positive cash flow from operations.
In the past 5 years IRM has always been profitable.
In the past 5 years IRM always reported a positive cash flow from operatings.
IRM Yearly Net Income VS EBIT VS OCF VS FCFIRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

The Return On Assets of IRM (0.96%) is worse than 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.11%, IRM is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IRM is in line with the industry average of 5.41%.
The 3 year average ROIC (5.88%) for IRM is below the current ROIC(6.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.96%
ROE N/A
ROIC 6.11%
ROA(3y)1.82%
ROA(5y)2.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.88%
ROIC(5y)5.9%
IRM Yearly ROA, ROE, ROICIRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

IRM has a Profit Margin of 2.93%. This is in the lower half of the industry: IRM underperforms 75.00% of its industry peers.
IRM's Profit Margin has declined in the last couple of years.
IRM has a worse Operating Margin (19.72%) than 75.00% of its industry peers.
IRM's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 67.26%, IRM is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IRM has grown nicely.
Industry RankSector Rank
OM 19.72%
PM (TTM) 2.93%
GM 67.26%
OM growth 3Y-0.58%
OM growth 5Y1.53%
PM growth 3Y-33.64%
PM growth 5Y-14.13%
GM growth 3Y-1.38%
GM growth 5Y3.37%
IRM Yearly Profit, Operating, Gross MarginsIRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IRM is destroying value.
The number of shares outstanding for IRM has been increased compared to 1 year ago.
The number of shares outstanding for IRM has been increased compared to 5 years ago.
Compared to 1 year ago, IRM has a worse debt to assets ratio.
IRM Yearly Shares OutstandingIRM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IRM Yearly Total Debt VS Total AssetsIRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that IRM is in the distress zone and has some risk of bankruptcy.
IRM has a Altman-Z score of 0.97. This is comparable to the rest of the industry: IRM outperforms 57.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACC0.74
WACC8.26%
IRM Yearly LT Debt VS Equity VS FCFIRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

IRM has a Current Ratio of 0.55. This is a bad value and indicates that IRM is not financially healthy enough and could expect problems in meeting its short term obligations.
IRM has a Current ratio of 0.55. This is in the lower half of the industry: IRM underperforms 64.29% of its industry peers.
IRM has a Quick Ratio of 0.55. This is a bad value and indicates that IRM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.55, IRM is doing worse than 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
IRM Yearly Current Assets VS Current LiabilitesIRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for IRM have decreased by 0.00% in the last year.
The Earnings Per Share has been growing by 11.69% on average over the past years. This is quite good.
The Revenue has grown by 12.22% in the past year. This is quite good.
The Revenue has been growing slightly by 7.61% on average over the past years.
EPS 1Y (TTM)0%
EPS 3Y5.37%
EPS 5Y11.69%
EPS Q2Q%-3.85%
Revenue 1Y (TTM)12.22%
Revenue growth 3Y11.04%
Revenue growth 5Y7.61%
Sales Q2Q%11.37%

3.2 Future

Based on estimates for the next years, IRM will show a small growth in Earnings Per Share. The EPS will grow by 7.15% on average per year.
The Revenue is expected to grow by 7.75% on average over the next years.
EPS Next Y16.32%
EPS Next 2Y12.8%
EPS Next 3Y7.15%
EPS Next 5YN/A
Revenue Next Year9.14%
Revenue Next 2Y9%
Revenue Next 3Y7.75%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IRM Yearly Revenue VS EstimatesIRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
IRM Yearly EPS VS EstimatesIRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 51.27, IRM can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as IRM.
The average S&P500 Price/Earnings ratio is at 29.63. IRM is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 44.08, which means the current valuation is very expensive for IRM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IRM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, IRM is valued quite expensively.
Industry RankSector Rank
PE 51.27
Fwd PE 44.08
IRM Price Earnings VS Forward Price EarningsIRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IRM indicates a slightly more expensive valuation: IRM is more expensive than 67.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.4
IRM Per share dataIRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.14
PEG (5Y)4.39
EPS Next 2Y12.8%
EPS Next 3Y7.15%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.36%, IRM has a reasonable but not impressive dividend return.
In the last 3 months the price of IRM has falen by -22.94%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
IRM's Dividend Yield is slightly below the industry average, which is at 4.50.
IRM's Dividend Yield is a higher than the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 3.36%

5.2 History

The dividend of IRM has a limited annual growth rate of 1.86%.
IRM has paid a dividend for at least 10 years, which is a reliable track record.
IRM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.86%
Div Incr Years3
Div Non Decr Years3
IRM Yearly Dividends per shareIRM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

IRM pays out 438.25% of its income as dividend. This is not a sustainable payout ratio.
IRM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP438.25%
EPS Next 2Y12.8%
EPS Next 3Y7.15%
IRM Yearly Income VS Free CF VS DividendIRM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
IRM Dividend Payout.IRM Dividend Payout, showing the Payout Ratio.IRM Dividend Payout.PayoutRetained Earnings

IRON MOUNTAIN INC

NYSE:IRM (2/21/2025, 8:04:00 PM)

After market: 91.78 0 (0%)

91.78

-1.72 (-1.84%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustrySpecialized REITs
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners86.07%
Inst Owner Change0.78%
Ins Owners0.71%
Ins Owner Change-8.6%
Market Cap26.93B
Analysts76.92
Price Target120.8 (31.62%)
Short Float %2.76%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 3.36%
Yearly Dividend2.7
Dividend Growth(5Y)1.86%
DP438.25%
Div Incr Years3
Div Non Decr Years3
Ex-Date03-17 2025-03-17 (0.785)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.92%
Min EPS beat(2)-9.99%
Max EPS beat(2)-9.85%
EPS beat(4)1
Avg EPS beat(4)-5.65%
Min EPS beat(4)-9.99%
Max EPS beat(4)1.85%
EPS beat(8)4
Avg EPS beat(8)0.92%
EPS beat(12)7
Avg EPS beat(12)2.22%
EPS beat(16)10
Avg EPS beat(16)4.07%
Revenue beat(2)0
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-2.21%
Max Revenue beat(2)-0.73%
Revenue beat(4)2
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-2.21%
Max Revenue beat(4)0.95%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)2
Avg Revenue beat(12)-1.49%
Revenue beat(16)5
Avg Revenue beat(16)-1.08%
PT rev (1m)-0.1%
PT rev (3m)8.87%
EPS NQ rev (1m)-0.51%
EPS NQ rev (3m)6.84%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.32%
Valuation
Industry RankSector Rank
PE 51.27
Fwd PE 44.08
P/S 4.38
P/FCF N/A
P/OCF 22.51
P/B N/A
P/tB N/A
EV/EBITDA 19.4
EPS(TTM)1.79
EY1.95%
EPS(NY)2.08
Fwd EY2.27%
FCF(TTM)-2.24
FCFYN/A
OCF(TTM)4.08
OCFY4.44%
SpS20.96
BVpS-1.71
TBVpS-23.38
PEG (NY)3.14
PEG (5Y)4.39
Profitability
Industry RankSector Rank
ROA 0.96%
ROE N/A
ROCE 7.76%
ROIC 6.11%
ROICexc 6.17%
ROICexgc 10.48%
OM 19.72%
PM (TTM) 2.93%
GM 67.26%
FCFM N/A
ROA(3y)1.82%
ROA(5y)2.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.88%
ROIC(5y)5.9%
ROICexc(3y)5.95%
ROICexc(5y)5.98%
ROICexgc(3y)10.42%
ROICexgc(5y)10.9%
ROCE(3y)7.47%
ROCE(5y)7.49%
ROICexcg growth 3Y-1.19%
ROICexcg growth 5Y-0.22%
ROICexc growth 3Y1.92%
ROICexc growth 5Y3.27%
OM growth 3Y-0.58%
OM growth 5Y1.53%
PM growth 3Y-33.64%
PM growth 5Y-14.13%
GM growth 3Y-1.38%
GM growth 5Y3.37%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.15
Cap/Depr 205.79%
Cap/Sales 30.15%
Interest Coverage 1.57
Cash Conversion 56.61%
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 0.97
F-Score5
WACC8.26%
ROIC/WACC0.74
Cap/Depr(3y)166.84%
Cap/Depr(5y)132%
Cap/Sales(3y)24%
Cap/Sales(5y)19.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y5.37%
EPS 5Y11.69%
EPS Q2Q%-3.85%
EPS Next Y16.32%
EPS Next 2Y12.8%
EPS Next 3Y7.15%
EPS Next 5YN/A
Revenue 1Y (TTM)12.22%
Revenue growth 3Y11.04%
Revenue growth 5Y7.61%
Sales Q2Q%11.37%
Revenue Next Year9.14%
Revenue Next 2Y9%
Revenue Next 3Y7.75%
Revenue Next 5YN/A
EBIT growth 1Y9.27%
EBIT growth 3Y10.4%
EBIT growth 5Y9.25%
EBIT Next Year110.2%
EBIT Next 3Y35.93%
EBIT Next 5YN/A
FCF growth 1Y-183.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.47%
OCF growth 3Y16.4%
OCF growth 5Y4.36%